Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.

Purpose To update a clinical practice guideline (CPG) for the empirical management of fever and neutropenia (FN) in children with cancer and hematopoietic stem-cell transplantation recipients. Methods The International Pediatric Fever and Neutropenia Guideline Panel is a multidisciplinary and multinational group of experts in pediatric oncology and infectious diseases that includes a patient advocate. For questions of risk stratification and evaluation, we updated systematic reviews of observational studies. For questions of therapy, we conducted a systematic review of randomized trials of any intervention applied for the empirical management of pediatric FN. The Grading of Recommendation Assessment, Development and Evaluation approach was used to make strong or weak recommendations and to classify levels of evidence as high, moderate, low, or very low. Results Recommendations related to initial presentation, ongoing management, and empirical antifungal therapy of pediatric FN were reviewed; the most substantial changes were related to empirical antifungal therapy. Key differences from our 2012 FN CPG included the listing of a fourth-generation cephalosporin for empirical therapy in high-risk FN, refinement of risk stratification to define patients with high-risk invasive fungal disease (IFD), changes in recommended biomarkers and radiologic investigations for the evaluation of IFD in prolonged FN, and a weak recommendation to withhold empirical antifungal therapy in IFD low-risk patients with prolonged FN. Conclusion Changes to the updated FN CPG recommendations will likely influence the care of pediatric patients with cancer and those undergoing hematopoietic stem-cell transplantation. Future work should focus on closing research gaps and on identifying ways to facilitate implementation and adaptation.

[1]  B. Phillips,et al.  Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review , 2018, Journal of the Pediatric Infectious Diseases Society.

[2]  J. Beyene,et al.  Galactomannan, β-D-Glucan, and Polymerase Chain Reaction-Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  L. Dupuis,et al.  Strategies for Empiric Management of Pediatric Fever and Neutropenia in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review of Randomized Trials. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  C. Timmons,et al.  Application of a standardized screening protocol for diagnosis of invasive mold infections in children with hematologic malignancies , 2016, Supportive Care in Cancer.

[5]  D. Sharma,et al.  A clinical evaluation of efficacy and safety of cefepime monotherapy versus piperacillin-tazobactam in patients of paediatric age group with febrile neutropenia in a tertiary care centre of north India , 2016, Tropical doctor.

[6]  J. Wachowiak,et al.  Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide study. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  A. Sachdeva,et al.  Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children. , 2016, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[8]  W. Kamps,et al.  Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre study. , 2016, European journal of cancer.

[9]  N. Hijiya,et al.  Clinical utility of bronchoalveolar lavage and respiratory tract biopsies in diagnosis and management of suspected invasive respiratory fungal infections in children , 2015, Pediatric blood & cancer.

[10]  Jae Wook Lee,et al.  Clinical Features and Prognosis of Invasive Pulmonary Aspergillosis in Korean Children with Hematologic/Oncologic Diseases , 2015, Journal of Korean medical science.

[11]  Kunihiko Kobayashi,et al.  Comparison between piperacillin/tazobactam and cefepime monotherapies as an empirical therapy for febrile neutropenia in children with hematological and malignant disorders: A prospective, randomized study , 2015, Pediatric blood & cancer.

[12]  Sandeep Jain,et al.  Invasive Aspergillosis in Children With Acute Leukemia at a Resource-limited Oncology Center , 2015, Journal of pediatric hematology/oncology.

[13]  J. Møller,et al.  Importance of blood cultures from peripheral veins in pediatric patients with cancer and a central venous line , 2015, Pediatric blood & cancer.

[14]  W. Hofmann,et al.  Assessment of Aspergillus‐specific PCR as a screening method for invasive aspergillosis in paediatric cancer patients and allogeneic haematopoietic stem cell recipients with suspected infections , 2014, Mycoses.

[15]  F. Babl,et al.  Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: A randomised trial , 2014, Pediatric blood & cancer.

[16]  E. Lanino,et al.  Role of acute graft-versus-host disease in the risk of bacteremia and invasive fungal disease after allogeneic hemopoietic stem cell transplantation in children. Results from a single-center observational study. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  D. Walker,et al.  G239 Validation of two risk stratification guidelines in a one year cohort of febrile admissions in paediatric oncology patients in a UK centre , 2014, Archives of Disease in Childhood.

[18]  J. Boelens,et al.  Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients , 2014, Bone Marrow Transplantation.

[19]  M. O'Ryan,et al.  Prospective Validation of a Risk Prediction Model for Severe Sepsis in Children With Cancer and High-risk Febrile Neutropenia , 2013, The Pediatric infectious disease journal.

[20]  W. Hop,et al.  Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan , 2013, Pediatric pulmonology.

[21]  C. Portwine,et al.  Invasive fungal infections in paediatric acute myeloid leukaemia , 2013, Mycoses.

[22]  A. Chakrabarti,et al.  Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies , 2013, Mycoses.

[23]  A. Islam,et al.  Urinary Tract Infections in Pediatric Oncology Patients with Fever and Neutropenia , 2012, Pediatric hematology and oncology.

[24]  H. Koo,et al.  Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients , 2013, Pediatric blood & cancer.

[25]  A. Srinivasan,et al.  Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[26]  F. Gibson,et al.  Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  W. Hofmann,et al.  Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies. , 2012, The Journal of antimicrobial chemotherapy.

[28]  I. Xess,et al.  Diagnosis of invasive fungal infections using real‐time PCR assay in paediatric acute leukaemia induction , 2012, Mycoses.

[29]  V. Poggi,et al.  A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy‐induced febrile neutropenia in children , 2012, British journal of haematology.

[30]  S. Alexander,et al.  Updated Systematic Review and Meta-Analysis of the Performance of Risk Prediction Rules in Children and Young People with Febrile Neutropenia , 2012, PloS one.

[31]  B. Phillips,et al.  Utility of peripheral blood cultures in patients with cancer and suspected blood stream infections: a systematic review , 2012, Supportive Care in Cancer.

[32]  A. Borkhardt,et al.  Invasive Aspergillosis in Pediatric Oncology Patients: A Rare Event With Poor Prognosis – Case Analysis to Plan Better Targeted Prophylactic or Therapeutic Measurement , 2012, Klinische Pädiatrie.

[33]  A. Simon,et al.  First‐day step‐down to oral outpatient treatment versus continued standard treatment in children with cancer and low‐risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study , 2012, Pediatric blood & cancer.

[34]  S. Kaste,et al.  Diagnostic value of routine chest radiography in febrile, neutropenic children for early detection of pneumonia and mould infections , 2012, Supportive Care in Cancer.

[35]  T. Ariga,et al.  Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia , 2011, Pediatric blood & cancer.

[36]  V. Aquino,et al.  The diagnostic utility of routine chest radiography in the evaluation of the initial fever in patients undergoing hematopoietic stem cell , 2011, Pediatric blood & cancer.

[37]  G. Kaspers,et al.  Pyuria is absent during urinary tract infections in neutropenic patients , 2011, Pediatric blood & cancer.

[38]  W. Kamps,et al.  Validation of a new risk assessment model for predicting adverse events in children with fever and chemotherapy-induced neutropenia. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  M. Putti,et al.  Incidence of bacteremias and invasive mycoses in children with acute non‐lymphoblastic leukemia: Results from a multi‐center Italian study , 2010, Pediatric blood & cancer.

[40]  T. Lion,et al.  Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in immunocompromised pediatric patients , 2010, Leukemia.

[41]  E. Thébaud,et al.  Predicting the risk of severe bacterial infection in children with chemotherapy‐induced febrile neutropenia , 2010, Pediatric blood & cancer.

[42]  M. O'Ryan,et al.  Risk Factors Associated With Invasive Fungal Disease in Children With Cancer and Febrile Neutropenia: A Prospective Multicenter Evaluation , 2010, The Pediatric infectious disease journal.

[43]  C. Viscoli,et al.  Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[44]  Gene Feder,et al.  Development of the AGREE II, part 1: performance, usefulness and areas for improvement , 2010, Canadian Medical Association Journal.

[45]  H. Jafri,et al.  A Randomized, Double-Blind, Multicenter Study of Caspofungin Versus Liposomal Amphotericin B for Empiric Antifungal Therapy in Pediatric Patients With Persistent Fever and Neutropenia , 2010, The Pediatric infectious disease journal.

[46]  A. Simon,et al.  Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  C. Macintyre,et al.  Epidemiology of paediatric invasive fungal infections and a case‐control study of risk factors in acute leukaemia or post stem cell transplant , 2010, British journal of haematology.

[48]  N. Yonemoto,et al.  Diagnostic performance of urine dipstick testing in children with suspected UTI: a systematic review of relationship with age and comparison with microscopy , 2010, Acta paediatrica.

[49]  M. Martins,et al.  Antibioticoterapia oral versus endovenosa em crianças neutropênicas febris recebendo quimioterapia , 2009 .

[50]  Zhezhen Jin,et al.  Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[51]  P. Gaynon,et al.  Prospective Monitoring for Invasive Aspergillosis Using Galactomannan and Polymerase Chain Reaction in High Risk Pediatric Patients , 2009, Journal of pediatric hematology/oncology.

[52]  J. Chisholm,et al.  Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting. , 2009, European journal of cancer.

[53]  J. Chen,et al.  [Value of plasma beta-Glucan in early diagnosis of invasive fungal infection in children]. , 2009, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.

[54]  Wei-Ting Chen,et al.  Improving diagnosis of central venous catheter-related bloodstream infection by using differential time to positivity as a hospital-wide approach at a cancer hospital. , 2009, The Journal of infection.

[55]  P. Lugtenburg,et al.  Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: a prospective observational safety study. , 2009, European journal of cancer.

[56]  L. Gregianin,et al.  Oral vs. intravenous empirical antimicrobial therapy in febrile neutropenic patients receiving childhood cancer chemotherapy. , 2009, Jornal de pediatria.

[57]  R. Hehlmann,et al.  Detection of Aspergillus DNA by a nested PCR assay is able to improve the diagnosis of invasive aspergillosis in paediatric patients. , 2009, Journal of medical microbiology.

[58]  D. Ogunc,et al.  Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: A randomized and open‐label study , 2009, Pediatric blood & cancer.

[59]  R. Pandey,et al.  Randomized Control Trial Comparing Oral Amoxicillin-clavulanate and Ofloxacin With Intravenous Ceftriaxone and Amikacin as Outpatient Therapy in Pediatric Low-risk Febrile Neutropenia , 2009, Journal of pediatric hematology/oncology.

[60]  W. Woods,et al.  Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia , 2009, Cancer.

[61]  A. Petrilli,et al.  Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison. , 2008, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[62]  G. Palù,et al.  Assessment of the lightcycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with onco‐haematological diseases , 2008, Mycoses.

[63]  E. Marchiori,et al.  Pulmonary infections following bone marrow transplantation: high-resolution CT findings in 35 paediatric patients. , 2008, European journal of radiology.

[64]  N. Ahmed,et al.  Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study , 2007, Pediatric blood & cancer.

[65]  T. Ariga,et al.  Evaluation of Risk Factors for Invasive Fungal Infection After Allogeneic Stem Cell Transplantation in Pediatric Patients , 2007, Journal of pediatric hematology/oncology.

[66]  H. El-Mahallawy,et al.  Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients. , 2006, Medical mycology.

[67]  A. Oxman,et al.  Improving the use of research evidence in guideline development: introduction , 2006, Health research policy and systems.

[68]  B. de Camargo,et al.  A Proposed Score for Predicting Severe Infection Complications in Children With Chemotherapy-induced Febrile Neutropenia , 2006, Journal of pediatric hematology/oncology.

[69]  W. W. Wan Abdullah,et al.  Imaging features of fungal infection in immuno-suppressed patients in a local ward outbreak , 2006, Biomedical imaging and intervention journal.

[70]  N. Sarper,et al.  MONOTHERAPY WITH PIPERACILLIN/TAZOBACTAM VERSUS CEFEPIME AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIA IN PEDIATRIC CANCER PATIENTS: A Randomized Comparison , 2006, Pediatric hematology and oncology.

[71]  W. Kamps,et al.  Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[72]  W. Steinbach,et al.  Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation , 2005, Bone Marrow Transplantation.

[73]  T. Pysher,et al.  Pediatric Invasive Fungal Rhinosinusitis in Immunocompromised Children With Cancer , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[74]  C. Viscoli,et al.  Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: a 13-year experience at a single Italian institution. , 2005, European journal of cancer.

[75]  P. Grundy,et al.  Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia , 2005, BMC pediatrics.

[76]  Chin‐Yun Lee,et al.  Invasive fungal infection in children with persistent febrile neutropenia. , 2005, Journal of the Formosan Medical Association = Taiwan yi zhi.

[77]  Sungching C Glenn,et al.  Invasive Fungal Infections in Pediatric Oncology Patients: 11-Year Experience at a Single Institution , 2005, Journal of pediatric hematology/oncology.

[78]  R. van Furth,et al.  Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination , 1993, European Journal of Clinical Microbiology and Infectious Diseases.

[79]  C. Viscoli,et al.  CT of invasive pulmonary aspergillosis in children with cancer , 2005, Pediatric Radiology.

[80]  M. Cumsille,et al.  Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[81]  É. Renoult,et al.  Is routine chest radiography necessary for the initial evaluation of fever in neutropenic children with cancer? , 2004, Pediatric blood & cancer.

[82]  J. Tarrand,et al.  Differential Time to Positivity: A Useful Method for Diagnosing Catheter-Related Bloodstream Infections , 2004, Annals of Internal Medicine.

[83]  A. Hirt,et al.  Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. , 2003, Medical and pediatric oncology.

[84]  L. Casimir,et al.  Outpatient, sequential, parenteral‐oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease , 2003, Cancer.

[85]  A. Petrilli,et al.  Evaluation of ticarcillin/clavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma. , 2003, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[86]  Y. Lucero,et al.  Infección micótica profunda en niños con cáncer, neutropenia y fiebre, en Chile , 2002 .

[87]  M. O'Ryan,et al.  Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[88]  P. Breitfeld,et al.  Value of Electronic Data for Model Validation and Refinement: Bacteremia Risk in Children With Fever and Neutropenia , 2002, Journal of pediatric hematology/oncology.

[89]  W. Miller,et al.  Infections diagnosed in the first year after pediatric stem cell transplantation , 2002, The Pediatric infectious disease journal.

[90]  S. Parsons,et al.  Evaluation of Risk Prediction Criteria for Episodes of Febrile Neutropenia in Children With Cancer , 2002, Journal of pediatric hematology/oncology.

[91]  T. Lehrnbecher,et al.  Short Courses of Intravenous Empirical Antibiotic Treatment in Selected Febrile Neutropenic Children with Cancer , 2002, Infection.

[92]  M. Lin,et al.  Improving efficacy of antifungal therapy by polymerase chain reaction-based strategy among febrile patients with neutropenia and cancer. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[93]  M. O'Ryan,et al.  Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[94]  L. Casimir,et al.  Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia , 2001, Cancer.

[95]  P. Roberson,et al.  Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[96]  D. Hawkins,et al.  Computed tomography in the evaluation of febrile neutropenic pediatric oncology patients. , 2001, The Pediatric infectious disease journal.

[97]  K. Vettenranta,et al.  Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years , 2000, Bone Marrow Transplantation.

[98]  R. Klaassen,et al.  Randomized Placebo-Controlled Trial of Oral Antibiotics in Pediatric Oncology Patients at Low-Risk With Fever and Neutropenia , 2000, Journal of pediatric hematology/oncology.

[99]  J. McCullers,et al.  Candidal meningitis in children with cancer. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[100]  L. Casimir,et al.  Oral administration of cefixime to lower risk febrile neutropenic children with cancer , 2000, Cancer.

[101]  M. Mustafa,et al.  Use of amphotericin B colloidal dispersion in children. , 2000, Journal of pediatric hematology/oncology.

[102]  A. Petrilli,et al.  Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial. , 2000, Medical and pediatric oncology.

[103]  D. Snydman,et al.  Clinical Utility of Blood Cultures Drawn from Indwelling Central Venous Catheters in Hospitalized Patients with Cancer , 1999, Annals of Internal Medicine.

[104]  J. Kuttesch,et al.  Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients , 1999, Cancer.

[105]  S. Richardson,et al.  Peripheral vs. central blood cultures in patients admitted to a pediatric oncology ward. , 1999, The Pediatric infectious disease journal.

[106]  H. Winer-Muram,et al.  Pulmonary complications in children with hematologic malignancies: accuracy of diagnosis with chest radiography and CT. , 1997, Radiology.

[107]  G. Buchanan,et al.  Early discharge of low-risk febrile neutropenic children and adolescents with cancer. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[108]  L. Avendaño,et al.  Discontinuation of antimicrobial therapy for febrile, neutropenic children with cancer: a prospective study. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[109]  J. Humbert,et al.  Early Hospital Discharge of Children with Fever and Neutropenia: A Prospective Study , 1997, Journal of pediatric hematology/oncology.

[110]  P. Vial,et al.  Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. , 1997, Medical and pediatric oncology.

[111]  M. Mustafa,et al.  Safety of early hospital discharge of selected febrile children and adolescents with cancer with prolonged neutropenia. , 1997, Medical and pediatric oncology.

[112]  R. Gonin,et al.  Predicting the risk of bacteremia in childen with fever and neutropenia. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[113]  R. Marcus,et al.  Short-course intravenous antibiotics with oral quinolone prophylaxis in the treatment of neutropenic fever in autologous bone marrow or peripheral blood progenitor cell transplant recipients. , 1996, Acta haematologica.

[114]  L. Odom,et al.  Cessation of Antibiotics Regardless of ANC Is Safe in Children with Febrile Neutropenia: A Preliminary Prospective Trial , 1995, Journal of pediatric hematology/oncology.

[115]  M. Rozenberg-Arska,et al.  Discontinuation of intravenous antibiotic therapy during persistent neutropenia in patients receiving prophylaxis with oral ciprofloxacin. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[116]  A. Haddad Comparison of cefoperazone-sulbactam versus piperacillin plus amikacin as empiric therapy in pediatric febrile neutropenic cancer patients , 1995 .

[117]  G. Buchanan,et al.  Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia , 1994, Cancer.

[118]  A. Tomiak,et al.  Duration of intravenous antibiotics for patients with neutropenic fever. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[119]  G. Buchanan,et al.  Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: implications for discontinuation of antibiotics and early discharge from the hospital. , 1992, The Journal of pediatrics.

[120]  A. Kaplan,et al.  Short courses of antibiotics in selected febrile neutropenic patients. , 1991, The American journal of the medical sciences.

[121]  K. Kavanagh,et al.  Fungal Sinusitis in Immunocompromised Children with Neoplasms , 1991, The Annals of otology, rhinology, and laryngology.

[122]  B. Leventhal,et al.  Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[123]  C. Mullen,et al.  Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[124]  J. Tenney,et al.  Can antibacterial therapy be discontinued in persistently febrile granulocytopenic cancer patients? , 1984, The American journal of medicine.

[125]  D. Parham,et al.  Computed tomography of hepatic and splenic fungal abscesses in leukemic children , 1982, Pediatric infectious disease.

[126]  R. Simon,et al.  Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. , 1979, The American journal of medicine.

[127]  E. Henderson,et al.  A study of antibiotic therapy in fever of unknown origin in neutropenic cancer patients. , 1977, Medical and pediatric oncology.

[128]  Joshua Lederberg,et al.  Children's Hospital of Philadelphia. , 1975, The Australasian nurses journal.